|
2024
|
Invention
|
Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione.
The present invention relates ... |
|
|
Invention
|
5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus. The p... |
|
|
Invention
|
5-amino-2,3-dihydro-1,4-phthalazinedione for the prophylaxis and treatment of thrombotic disorder... |
|
2023
|
Invention
|
Combination of 5-amino-2,3-dihydro-1,4-phthalazinedione and a fumaric acid ester. The present app... |
|
|
Invention
|
Combination of budesonide and 5-amino-2,3-dihydro-1,4-phthalazinedione. The present invention rel... |
|
|
Invention
|
Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of congenital muscular dystrophi... |
|
2022
|
Invention
|
Combination of 5-amino-2,3-dihydro-1,4-phtalazinedione and a 6'-methoxycinchonan-9-ol for use in ... |
|
2021
|
Invention
|
Luminol for the prophylaxis and the treatment of sequelae of a sars-cov-2 infection.
The present... |
|
|
Invention
|
Luminol for the prophylaxis and the treatment of sequelae of a sars-cov-2 infection. The present ... |
|
|
Invention
|
Glucocorticoid-sparing agent.
5-amino-2,3-dihydro-1,4-phthalazinedione or one of its pharmaceuti... |
|
|
Invention
|
Glucocorticoid-sparing agent. 5 -amino-2,3 -dihydro- 1,4-phthalazinedione or one of its pharmaceu... |
|
|
Invention
|
Compound for the treatment of coronaviral infections.
The present application relates to the use... |
|
|
Invention
|
Compound for the treatment of coronaviral infections. The present application relates to the use ... |
|
|
Invention
|
5-amino-2,3-dihydro-1,4-phthalazinedione for treatment of acute lung injury.
The present inventi... |
|
|
Invention
|
5-amino-2,3-dihydro-1,4-phthalazinedione for treatment of acute lung injury. The present inventio... |
|
|
Invention
|
Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the inhalatory treatment of inflammatory pulmo... |
|
|
Invention
|
Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pul... |
|
2019
|
Invention
|
Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione. The present invention relates t... |
|
2017
|
Invention
|
Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple ... |
|
|
Invention
|
Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of inflammatory and/or degenerat... |
|
|
Invention
|
Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione. A new metho... |
|
|
Invention
|
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione. A new crystalline form of 5-amino-2... |
|
|
Invention
|
Method for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione. A new method... |
|
2015
|
Invention
|
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparat... |
|
2014
|
Invention
|
Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical prepar... |
|
2011
|
Invention
|
Crystalline forms for 5-amino-2, 3-dihydrophthalazine-1, 4-dione sodium salt, pharmaceutical prep... |
|
|
Invention
|
Crystalline forms of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical prepara... |
